CD4 and Miyoshi myopathy: MM patients displaying <1.8% B cells and <12.4% CD4+ T cells before the booster had a greater probability of achieving inadequate anti-RBD IgG concentration after (AUC = 0.8, P = 0.001) (Fig. 4B).